Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on February 8, 2006
J Am Soc Nephrol 17: 831-836, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2005050493

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005050493v1
17/3/831    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKnight, A. J.
Right arrow Articles by Savage, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKnight, A. J.
Right arrow Articles by Savage, D. A.

Human Genetics

A Genome-Wide DNA Microsatellite Association Screen to Identify Chromosomal Regions Harboring Candidate Genes in Diabetic Nephropathy

Amy Jayne McKnight*, A. Peter Maxwell*, Stephen Sawcer{dagger}, Alastair Compston{dagger}, Efrosini Setakis{ddagger}, Chris C. Patterson§, Hugh R. Brady|| and David A. Savage*

* Nephrology Research Group; § Department of Epidemiology & Public Health, Queen’s University Belfast, Belfast, Northern Ireland; {dagger} Department of Neurology, University of Cambridge, Cambridge, United Kingdom; {ddagger} Department of Epidemiology and Public Health, Imperial College, London, United Kingdom; and || Conway Institute, University College Dublin, Dublin, Ireland

Address correspondence to: Dr. David A. Savage, Nephrology Research Group, Queen’s University Belfast, c/o Medical Genetics, Floor A, Tower Block, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, Northern Ireland. Phone: +44-0-28-90329241 ext. 2149; Fax: +44-0-28-90236911; d.savage{at}qub.ac.uk

Received for publication May 12, 2005. Accepted for publication January 3, 2006.

In an effort to accelerate the identification of susceptibility genes in diabetic nephropathy, the first genome-wide fluorescence-based DNA microsatellite (n = 6000) association screen was performed, using pools of genomic DNA derived from Irish patients with (cases; n = 200) and without (controls; n = 200) type 1 diabetic nephropathy. Allele image profiles were generated for 5353 (89.2%) microsatellite markers for both case and control pools. Allele counts (estimated from allele image profiles) were compared in case versus control groups, and empirical P values were generated. Markers then were ranked on the basis of their empirical P values (lowest to highest). Repeat PCR amplification and electrophoresis of pooled samples were performed systematically on ranked markers until the 50 most associated markers with consistent results were identified. DNA samples that composed the pools then were genotyped individually for these markers. Two markers on chromosome 10, D10S558 (Pcorrected = 0.005) and D10S1435 (Pcorrected = 0.016), revealed statistically significant associations with diabetic nephropathy. An additional four markers (D6S281, D4S2937, D2S291, and D17S515) also are worthy of further investigation. Relevant functional candidate genes have been identified in the vicinity of these markers, demonstrating the feasibility of low-resolution genome-wide microsatellite association screening to identify possible candidate genes for diabetic nephropathy.




This article has been cited by other articles:


Home page
Ther Adv Cardiovasc DisHome page
S. Maeda
Review: Genetics of diabetic nephropathy
Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 363 - 371.
[Abstract] [PDF]


Home page
DiabetesHome page
H. Al-Kateb, A. P. Boright, L. Mirea, X. Xie, R. Sutradhar, A. Mowjoodi, B. Bharaj, M. Liu, J. M. Bucksa, V. L. Arends, et al.
Multiple Superoxide Dismutase 1/Splicing Factor Serine Alanine 15 Variants Are Associated With the Development and Progression of Diabetic Nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics Study
Diabetes, January 1, 2008; 57(1): 218 - 228.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
B. I. Freedman, M. Bostrom, P. Daeihagh, and D. W. Bowden
Genetic Factors in Diabetic Nephropathy
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1306 - 1316.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. K. Iyengar, H. E. Abboud, K. A.B. Goddard, M. F. Saad, S. G. Adler, N. H. Arar, D. W. Bowden, R. Duggirala, R. C. Elston, R. L. Hanson, et al.
Genome-Wide Scans for Diabetic Nephropathy and Albuminuria in Multiethnic Populations: The Family Investigation of Nephropathy and Diabetes (FIND)
Diabetes, June 1, 2007; 56(6): 1577 - 1585.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. I. Freedman, D. W. Bowden, M. M. Sale, C. D. Langefeld, and S. S. Rich
Genetic Susceptibility Contributes to Renal and Cardiovascular Complications of Type 2 Diabetes Mellitus
Hypertension, July 1, 2006; 48(1): 8 - 13.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP